Close

Tetraphase Pharma (TTPH) Announces Dosing of First IGNITE4 Phase 3 Patient

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. HCP


Go back to Tetraphase Pharma (TTPH) Announces Dosing of First IGNITE4 Phase 3 Patient
TETRAPH PHARMA (NASDAQ: TTPH) Delayed: 2.20 --0 (-0%)
Previous Close $2.20    52 Week High $12.45 
Open $17.31    52 Week Low $3.11 
Day High $2.20    P/E N/A 
Day Low $2.20    EPS $-2.70 
Volume 105,485